vimarsana.com
Home
Live Updates
Sebela Women's Health Announces Positive Phase 3 Data for it
Sebela Women's Health Announces Positive Phase 3 Data for it
Sebela Women's Health Announces Positive Phase 3 Data for its Investigational, Next-Generation, Hormone-Free, Low-Dose Copper Intrauterine Device (IUD)
/PRNewswire/ -- Sebela Women's Health Inc., a part of Sebela Pharmaceuticals, today announced positive results of a Phase 3 study demonstrating that...
Related Keywords
Dublin ,
Ireland ,
United States ,
Kelly Culwell ,
Davidk Turok ,
Sebela Women Health Inc ,
American College Of Obstetrics ,
Us Food Drug Administration ,
Prnewswire Sebela Women Health Inc ,
Sebela Pharmaceuticals ,
Department Of Obstetrics ,
Sebela Pharmaceuticals Inc ,
Committee Statement ,
Sebela Women Health ,
Drug Administration Staff ,
University Of Utah ,
Braintree Laboratories Inc ,
Head Of Research ,
Drug Administration ,
Health Inc ,
Pearl Index ,
Sebela Women ,
Principal Investigator David ,
Associate Professor ,
Scientific Meeting ,
American College ,
Private Securities Litigation Reform Act ,
Technical Considerations ,
Non Clinical Assessment ,
Medical Devices Containing Nitinol Guidance ,
Clinical Practice Bulletin ,
Englj Med ,